Probiotics do reduce body fat. The honest number is 0.86 kg. An umbrella review in Probiotics and Antimicrobial Proteins gathered 5 systematic reviews and 18 meta-analyses of probiotic supplementation in overweight and obese adults and pooled what they found. Body fat mass fell by 0.86 kg (95% CI, -1.02 to -0.71; p < 0.00001), BMI by 0.30 kg/m2 (95% CI, -0.36 to -0.25), and body weight by 0.59 kg (95% CI, -0.74 to -0.44). Those are statistically solid results sitting on top of a physically small change: less than a kilogram of fat, or under two pounds, across months of daily supplementation.
The dose that separated the trials that worked from the ones that did not. A 2026 meta-analysis in Frontiers in Public Health, covering 12 randomized controlled trials in overweight and obese adults, reported a mean difference of -0.52 kg in body weight (95% CI, -0.90 to -0.13; p < 0.01), -0.22 kg/m2 in BMI, -0.29 cm at the waist (95% CI, -0.56 to -0.02; p = 0.03), and -0.59 percentage points in body fat percentage (95% CI, -0.96 to -0.21; p < 0.01). The subgroup analysis is the practically useful part: regimens using a single strain at a high dose, at least 1 x 10^10 CFU per day, or paired with dietary guidance, produced the clearer effects. Blood lipids did not move: total cholesterol MD = -2.94 mg/dL (95% CI, -6.05 to 0.17; p = 0.06) and triglycerides MD = -6.77 mg/dL (95% CI, -14.58 to 1.05; p = 0.09), neither of them statistically significant.
Which bacteria? The pooled reviews above will not tell you, but genus-level analyses will. "Probiotic" is not one thing, and averaging across organisms hides the differences between them. Two reviews narrow the question. For Lactobacillus species, a meta-analysis with GRADE assessment covering 12 clinical trials and 1,058 individuals with obesity and no other diagnoses found BMI down 0.40 kg/m2 (95% CI, -0.48 to -0.32; p < 0.00001), body weight MD: -1.16 kg (95% CI, -1.79 to -0.53; p = 0.0003), waist circumference MD: -1.41 cm (95% CI, -1.75 to -1.08), hip circumference MD: -0.85 cm, visceral and subcutaneous fat mass MD: -7.35 (95% CI, -9.95 to -4.75), and overall body fat MD: -1.11 (95% CI, -1.31 to -0.91). Leptin fell (MD: -2.11 ug/mL; p=0.005) and adiponectin rose (MD: 0.71 ug/mL; p=0.004), which is the hormonal signature you would expect if fat stores were shrinking. No significant adverse events were reported in either group.
Bifidobacterium moves body fat without moving the scale. A separate systematic review of 11 studies with 911 subjects, restricted to Bifidobacterium and deliberately excluding multi-strain mixtures, found reductions in body fat mass (MD = -0.64 kg; 95% CI, -1.09 to -0.18; p = 0.006), body fat percentage (MD = -0.64%; 95% CI, -1.18 to -0.11; p = 0.02), waist circumference (MD = -1.39 cm; 95% CI, -1.99 to -0.79; p < 0.00001), and visceral fat area (MD = -4.38 cm2; 95% CI, -7.24 to -1.52; p = 0.003), while body weight, BMI, and the waist-to-hip ratio showed no significant difference. Its authors close by asking for research on which species and strains work best, on optimal doses, and even on whether capsules, powders, or enriched foods deliver them better, which is a fair summary of how unsettled the practical details still are. Read alongside the Lactobacillus findings, that is the clearest available answer to the strain question: the two most-studied genera both act on fat, and they do not act identically. It is also a reason to distrust any product claim that treats "probiotics" as a single ingredient with a single effect.
A third analysis found the fat but not the BMI. In Scientific Reports, a meta-analysis of 8 randomized controlled trials with 412 patients found significant reductions in body weight (P < 0.00001), waist circumference (P = 0.01), and visceral fat content (P < 0.00001) among people taking oral probiotics, while BMI and LDL cholesterol showed no significant difference from control. That pattern, movement in fat and waist measurements without movement in BMI, recurs across this literature and is a reminder that BMI is a blunt instrument for detecting small shifts in body composition.
Why the certainty is lower than the p-values suggest. The umbrella review authors are explicit that the credibility of the evidence is limited by poor-quality study designs and small participant numbers, and they call for larger, more robust trials before anyone treats probiotics as an obesity intervention. The 2026 analysis drew predominantly on trials from East Asia, which raises the question of how well the findings transfer to other populations and diets. And because effects appear to be strain-specific, results pooled across different organisms may understate what a well-matched strain does and overstate what an arbitrary one does.
What this means if you are standing in the supplement aisle. The realistic expectation from a probiotic supplement is a fraction of a kilogram of fat over months, not a visible change in body shape, and it will not do anything measurable to your cholesterol. If a product is worth trying for other reasons, the dose used in the trials that showed an effect was at least 10 billion CFU per day of a single strain rather than a low-dose blend, and the organisms with the most human data behind them are Lactobacillus and Bifidobacterium species. None of these reviews compares commercial products or names a specific strain as best, so nothing here identifies a brand worth buying, and a label listing many strains at unstated doses matches nothing that has been tested.
Bottom line. Probiotic supplements are associated with about 0.86 kg less body fat, half a kilogram less body weight, and a third of a centimeter off the waist. The direction is consistent and the effect is small, the evidence base is weaker than the number of published meta-analyses makes it look, and the fundamentals of eating and movement still do the work.
Medical note. This article is for general educational purposes only and is not intended as personal medical advice.